Home
NICE Guidance
Conditions and diseases
Musculoskeletal conditions
Arthritis
Tocilizumab for the treatment of systemic juvenile idiopathic arthritis
Technology appraisal guidance [TA238]
Published:
14 December 2011
Guidance
Tools and resources
Information for the public
History
Do no do examples
Do no do examples for Tocilizumab for the treatment of systemic juvenile idiopathic arthritis
Title
Year published
Impact Level
No results could be found